• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌血管生成的研究进展:对诊断、预后和治疗的影响。

Advances in Understanding Hepatocellular Carcinoma Vasculature: Implications for Diagnosis, Prognostication, and Treatment.

机构信息

Department of Radiology, Research Institute of Radiological Science, Center for Clinical Imaging Data Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, Republic of Korea.

出版信息

Korean J Radiol. 2024 Oct;25(10):887-901. doi: 10.3348/kjr.2024.0307.

DOI:10.3348/kjr.2024.0307
PMID:39344546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11444852/
Abstract

Hepatocellular carcinoma (HCC) progresses through multiple stages of hepatocarcinogenesis, with each stage characterized by specific changes in vascular supply, drainage, and microvascular structure. These vascular changes significantly influence the imaging findings of HCC, enabling non-invasive diagnosis. Vascular changes in HCC are closely related to aggressive histological characteristics and treatment responses. Venous drainage from the tumor toward the portal vein in the surrounding liver facilitates vascular invasion, and the unique microvascular pattern of vessels that encapsulate the tumor cluster (known as a VETC pattern) promotes vascular invasion and metastasis. Systemic treatments for HCC, which are increasingly being used, primarily target angiogenesis and immune checkpoint pathways, which are closely intertwined. By understanding the complex relationship between histopathological vascular changes in hepatocarcinogenesis and their implications for imaging findings, radiologists can enhance the accuracy of imaging diagnosis and improve the prediction of prognosis and treatment response. This, in turn, will ultimately lead to better patient care.

摘要

肝细胞癌 (HCC) 经过多个肝癌发生阶段进展,每个阶段的特征为血管供应、引流和微血管结构的特定变化。这些血管变化显著影响 HCC 的影像学表现,使非侵入性诊断成为可能。HCC 的血管变化与侵袭性组织学特征和治疗反应密切相关。肿瘤向周围肝脏门静脉的静脉引流促进了血管侵犯,而包裹肿瘤簇的独特微血管模式(称为 VETC 模式)促进了血管侵犯和转移。HCC 越来越多地使用的系统治疗主要针对血管生成和免疫检查点途径,这两者密切相关。通过了解肝癌发生过程中组织病理学血管变化的复杂关系及其对影像学发现的影响,放射科医生可以提高影像学诊断的准确性,并改善对预后和治疗反应的预测。这反过来将最终为患者带来更好的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/063e/11444852/f8e56e368fa6/kjr-25-887-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/063e/11444852/d929d92c13bd/kjr-25-887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/063e/11444852/9f90e69187ca/kjr-25-887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/063e/11444852/0009b079ab39/kjr-25-887-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/063e/11444852/407989884ae0/kjr-25-887-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/063e/11444852/267d9b235a29/kjr-25-887-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/063e/11444852/908ad9e331b9/kjr-25-887-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/063e/11444852/f8e56e368fa6/kjr-25-887-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/063e/11444852/d929d92c13bd/kjr-25-887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/063e/11444852/9f90e69187ca/kjr-25-887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/063e/11444852/0009b079ab39/kjr-25-887-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/063e/11444852/407989884ae0/kjr-25-887-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/063e/11444852/267d9b235a29/kjr-25-887-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/063e/11444852/908ad9e331b9/kjr-25-887-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/063e/11444852/f8e56e368fa6/kjr-25-887-g007.jpg

相似文献

1
Advances in Understanding Hepatocellular Carcinoma Vasculature: Implications for Diagnosis, Prognostication, and Treatment.肝细胞癌血管生成的研究进展:对诊断、预后和治疗的影响。
Korean J Radiol. 2024 Oct;25(10):887-901. doi: 10.3348/kjr.2024.0307.
2
Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis.肝细胞癌的无创性影像学诊断与预后评估。
World J Gastroenterol. 2018 Jun 14;24(22):2348-2362. doi: 10.3748/wjg.v24.i22.2348.
3
Radiomics Model of Dynamic Contrast-Enhanced MRI for Evaluating Vessels Encapsulating Tumor Clusters and Microvascular Invasion in Hepatocellular Carcinoma.动态对比增强磁共振成像的影像组学模型用于评估肝细胞癌中包绕肿瘤结节的血管及微血管侵犯
Acad Radiol. 2025 Jan;32(1):146-156. doi: 10.1016/j.acra.2024.07.007. Epub 2024 Jul 18.
4
Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma.基于钆塞酸二钠增强 MRI 的影像学特征预测肝细胞癌患者肿瘤簇包绕血管(VETC)。
Br J Radiol. 2021 Mar 1;94(1119):20200950. doi: 10.1259/bjr.20200950. Epub 2021 Jan 20.
5
Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma.血管包裹肿瘤簇(VETC)是预测侵袭性肝细胞癌的有力指标。
Hepatology. 2020 Jan;71(1):183-195. doi: 10.1002/hep.30814. Epub 2019 Aug 9.
6
Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis.肝硬化中的肝细胞结节:血流动力学评估(血管造影辅助CT),特别提及多步骤肝癌发生过程
Abdom Imaging. 2011 Jun;36(3):264-72. doi: 10.1007/s00261-011-9685-1.
7
Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma: clinical and biological significance.对比增强术中超声用于肝细胞癌的血管成像:临床和生物学意义。
Hepatology. 2013 Apr;57(4):1436-47. doi: 10.1002/hep.26122. Epub 2013 Jan 25.
8
Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.基于彩色多普勒血流动力学的肝细胞癌血供特征个体化治疗模型
Hepatogastroenterology. 2007 Mar;54(74):334-41.
9
Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma.肝细胞癌患者中同时存在低血供和高血供结节的预后意义
PLoS One. 2016 Sep 20;11(9):e0163119. doi: 10.1371/journal.pone.0163119. eCollection 2016.
10
Vascular changes in hepatocellular carcinoma: correlation of radiologic and pathologic findings.肝细胞癌中的血管变化:放射学与病理学发现的相关性
AJR Am J Roentgenol. 1999 Nov;173(5):1213-7. doi: 10.2214/ajr.173.5.10541091.

引用本文的文献

1
Spectral computed tomography parameters for predicting vessels encapsulating tumor clusters (VETC) pattern in hepatocellular carcinoma: a pilot study.用于预测肝细胞癌中肿瘤团块包绕血管(VETC)模式的光谱计算机断层扫描参数:一项初步研究。
Quant Imaging Med Surg. 2025 Apr 1;15(4):3285-3297. doi: 10.21037/qims-24-2077. Epub 2025 Mar 28.
2
Demonstration of Hepatic Vein Abnormalities Using Contrast-Enhanced Sonography in Liver Diseases.利用超声造影在肝脏疾病中显示肝静脉异常
Diagnostics (Basel). 2025 Mar 12;15(6):709. doi: 10.3390/diagnostics15060709.
3
Construction of nomogram model based on contrast-enhanced ultrasound parameters to predict the degree of pathological differentiation of hepatocellular carcinoma.

本文引用的文献

1
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide.肝细胞癌病因及流行病学的变化:亚洲及全球情况
J Liver Cancer. 2024 Mar;24(1):62-70. doi: 10.17998/jlc.2024.03.13. Epub 2024 Mar 25.
2
A multidisciplinary approach with immunotherapies for advanced hepatocellular carcinoma.针对晚期肝细胞癌的免疫疗法多学科治疗方法。
J Liver Cancer. 2023 Sep;23(2):316-329. doi: 10.17998/jlc.2023.09.04. Epub 2023 Sep 22.
3
Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.
基于超声造影参数构建列线图模型以预测肝细胞癌病理分化程度
Front Oncol. 2025 Jan 27;15:1519703. doi: 10.3389/fonc.2025.1519703. eCollection 2025.
4
Bioinformatics analysis and experimental validation of as a potential prognostic marker and therapeutic target for liver hepatocellular carcinoma.作为肝细胞癌潜在预后标志物和治疗靶点的生物信息学分析及实验验证
Biomol Biomed. 2025 Mar 7;25(4):925-939. doi: 10.17305/bb.2024.11246.
使用钆塞酸增强 MRI 对米兰标准内单个肝细胞癌进行术前微血管侵犯风险评估,以预测肝移植术后的结局。
Eur Radiol. 2024 Jan;34(1):498-508. doi: 10.1007/s00330-023-09936-y. Epub 2023 Jul 28.
4
Vessels that encapsulate tumour clusters vascular pattern in hepatocellular carcinoma.包裹肿瘤簇的血管在肝细胞癌中的血管模式。
JHEP Rep. 2023 May 11;5(8):100792. doi: 10.1016/j.jhepr.2023.100792. eCollection 2023 Aug.
5
An Imaging Feature Predicts Efficacy of Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma.一种影像学特征可预测阿替利珠单抗联合贝伐单抗治疗不可切除肝细胞癌的疗效。
Cancer Diagn Progn. 2023 Jul 3;3(4):468-474. doi: 10.21873/cdp.10241. eCollection 2023 Jul-Aug.
6
Transarterial Chemoembolization for Hepatocellular Carcinoma: 2023 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association.经动脉化疗栓塞术治疗肝细胞癌:韩国肝癌协会基于 2023 年专家共识的实用推荐建议。
Korean J Radiol. 2023 Jul;24(7):606-625. doi: 10.3348/kjr.2023.0385.
7
Radiologic features of hepatocellular carcinoma related to prognosis.肝细胞癌的放射学特征与预后的关系
J Liver Cancer. 2023 Mar;23(1):143-156. doi: 10.17998/jlc.2023.02.16. Epub 2023 Mar 9.
8
Radioembolization for hepatocellular carcinoma: what clinicians need to know.肝细胞癌的放射性栓塞治疗:临床医生需要了解的内容。
J Liver Cancer. 2022 Mar;22(1):4-13. doi: 10.17998/jlc.2022.01.16. Epub 2022 Feb 23.
9
Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment.低基线CXCL9可预测阿替利珠单抗联合贝伐单抗治疗不可切除肝癌的早期疾病进展
Liver Cancer. 2022 Oct 31;12(2):156-170. doi: 10.1159/000527759. eCollection 2023 Jun.
10
Inter-observer agreement and accuracy of LI-RADS v2018 for differentiating tumor in vein from bland thrombus using gadoxetic acid-enhanced magnetic resonance imaging.LI-RADS v2018 对钆塞酸增强磁共振成像鉴别静脉内肿瘤与单纯性血栓的观察者间一致性和准确性。
Abdom Radiol (NY). 2023 Aug;48(8):2557-2569. doi: 10.1007/s00261-023-03964-4. Epub 2023 May 29.